1. Home
  2. KBR vs LEGN Comparison

KBR vs LEGN Comparison

Compare KBR & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KBR
  • LEGN
  • Stock Information
  • Founded
  • KBR 1901
  • LEGN 2014
  • Country
  • KBR United States
  • LEGN United States
  • Employees
  • KBR N/A
  • LEGN N/A
  • Industry
  • KBR Military/Government/Technical
  • LEGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • KBR Industrials
  • LEGN Health Care
  • Exchange
  • KBR Nasdaq
  • LEGN Nasdaq
  • Market Cap
  • KBR 6.3B
  • LEGN 5.4B
  • IPO Year
  • KBR 2006
  • LEGN 2020
  • Fundamental
  • Price
  • KBR $47.62
  • LEGN $35.64
  • Analyst Decision
  • KBR Buy
  • LEGN Strong Buy
  • Analyst Count
  • KBR 7
  • LEGN 13
  • Target Price
  • KBR $64.33
  • LEGN $75.17
  • AVG Volume (30 Days)
  • KBR 1.5M
  • LEGN 2.0M
  • Earning Date
  • KBR 07-31-2025
  • LEGN 08-08-2025
  • Dividend Yield
  • KBR 1.39%
  • LEGN N/A
  • EPS Growth
  • KBR N/A
  • LEGN N/A
  • EPS
  • KBR 2.98
  • LEGN N/A
  • Revenue
  • KBR $7,979,000,000.00
  • LEGN $728,303,000.00
  • Revenue This Year
  • KBR $14.27
  • LEGN $65.49
  • Revenue Next Year
  • KBR $8.57
  • LEGN $53.76
  • P/E Ratio
  • KBR $15.99
  • LEGN N/A
  • Revenue Growth
  • KBR 12.84
  • LEGN 112.46
  • 52 Week Low
  • KBR $43.89
  • LEGN $27.34
  • 52 Week High
  • KBR $72.60
  • LEGN $60.87
  • Technical
  • Relative Strength Index (RSI)
  • KBR 33.92
  • LEGN 57.79
  • Support Level
  • KBR $46.54
  • LEGN $32.42
  • Resistance Level
  • KBR $48.62
  • LEGN $36.91
  • Average True Range (ATR)
  • KBR 1.26
  • LEGN 1.42
  • MACD
  • KBR -0.30
  • LEGN 0.02
  • Stochastic Oscillator
  • KBR 13.78
  • LEGN 67.58

About KBR KBR Inc.

KBR, formerly Kellogg Brown & Root, is global provider of technology, integrated engineering, procurement, and construction delivery, and operations and maintenance services. The company's business is organized into two segments: government solutions and sustainable technology solutions. KBR has operations in over 30 countries and employs approximately 34,000 people. The firm generated $7.7 billion in revenue in 2024.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: